Based on our advanced algorithm, we predict that DMAC stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $4.93, while the 1-week outlook suggests a value of $4.83. For the 1-month forecast, we project a price of $4.74. Looking further ahead, our 2026 projection estimates a value of $4.29, with a long-term 2030 forecast reaching $6.14. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DMAC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
DMAC stock price ended at $5.05 on Friday, after rising3.48%
The DiaMedica Therapeutics Inc stock price increased by 3.48% on the last trading day (25 Jul 2025), rising from 5.09 to 4.88. Throughout the last trading session, the stock experienced a fluctuation of 5.74% , ranging from a day low of $4.88 to a day high of 5.16. The price has declined in 4 of the last 10 days, resulting in a total change of 32.97% during this period. On the last day, trading volume decrease by -305.25K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 322.59K shares were traded, amounting to approximately 1.63M.
DMAC Technical Signals
DMAC(DiaMedica Therapeutics Inc Corp) has 5 buy signals and 3 sell signals now. The current trend is uptrend starting from 2025-07-17. The total price change during this trend is +24.17%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of DMAC over the last 5 trading days is 2.53M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
DMAC Moving Average Analysis
DiaMedica Therapeutics Inc's overall moving average trend leans more bullish as of Friday, July 25, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $5.42, and $6.06. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $3.35, and $2.71. A break-down below any of these levels will issue sell signals.
DMAC Short Selling Analysis
The short sale ratio of DiaMedica Therapeutics Inc(DMAC) as of 23 Jul 2025 is 24.10%, rising from last trading day. With increasing price from 4.60 to 5.15. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Buy
Sell
3
Buy
5
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.646
Bullish
Momentum (10 days)
MOM_10 > 0
1.21
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.233
Bullish
Moving Average
5-day SMA crosses above 250-day SMA
--
Bullish
Moving Average
20-day SMA crosses above 60-day SMA
--
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, DiaMedica Therapeutics Inc (DMAC) is anticipated to change hands in a trading channel between $3.55 and $5.50.
DiaMedica Therapeutics Inc Stock Forecast 2026
Jan 2026: DMAC Stock Forecast
Potential ROI: -0.94%
In Jan 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.14. The price is predicted to fluctuate between a low of $3.63 and a high of $4.54.
Feb 2026: DMAC Stock Forecast
Potential ROI: 2.38%
In Feb 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.28. The price is predicted to fluctuate between a low of $4.23 and a high of $4.54.
Mar 2026: DMAC Stock Forecast
Potential ROI: 2.16%
In Mar 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.27. The price is predicted to fluctuate between a low of $3.90 and a high of $4.78.
Apr 2026: DMAC Stock Forecast
Potential ROI: 3.32%
In Apr 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.32. The price is predicted to fluctuate between a low of $4.24 and a high of $4.66.
May 2026: DMAC Stock Forecast
Potential ROI: 9.81%
In May 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.59. The price is predicted to fluctuate between a low of $4.26 and a high of $5.06.
Jun 2026: DMAC Stock Forecast
Potential ROI: 20.75%
In Jun 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $5.05. The price is predicted to fluctuate between a low of $4.95 and a high of $5.50.
Jul 2026: DMAC Stock Forecast
Potential ROI: 2.70%
In Jul 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.29. The price is predicted to fluctuate between a low of $3.97 and a high of $4.90.
Aug 2026: DMAC Stock Forecast
Potential ROI: 16.98%
In Aug 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.89. The price is predicted to fluctuate between a low of $4.66 and a high of $5.45.
Sep 2026: DMAC Stock Forecast
Potential ROI: -10.75%
In Sep 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $3.73. The price is predicted to fluctuate between a low of $3.55 and a high of $3.97.
Oct 2026: DMAC Stock Forecast
Potential ROI: 15.54%
In Oct 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.83. The price is predicted to fluctuate between a low of $4.71 and a high of $4.89.
Nov 2026: DMAC Stock Forecast
Potential ROI: 6.70%
In Nov 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.46. The price is predicted to fluctuate between a low of $3.93 and a high of $4.86.
Dec 2026: DMAC Stock Forecast
Potential ROI: 0.95%
In Dec 2026, DiaMedica Therapeutics Inc's value is forecasted to reach an average price of $4.22. The price is predicted to fluctuate between a low of $3.68 and a high of $4.83.
DMAC Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to DiaMedica Therapeutics Inc(DMAC), our algorithm predicts DMAC's 1-month price at $2.99, with an -17.76%downwardshift. Using a similarity score up to 94.23%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for DiaMedica Therapeutics Inc (DMAC.O) stock, as of Sunday, July 13, 2025 , forecasts a -17.76% change over the next month, based on its high correlation with EU.A stock patterns. The similarity between their price movements over the analyzed periods is 94.23%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
DMAC
Future prediction
Up: -17.76%
EU
Down: -17.76%Similarity: 94.23%
Name
Similarity
Up/Down
EU.A
94.23%
-17.76%
ELA.A
94.12%
-9.89%
SENEB.O
93.83%
-0.12%
ARCT.O
93.71%
+11.40%
MRCC.O
93.69%
-0.26%
HAL.N
93.50%
-1.71%
VC.O
93.47%
-10.23%
FTLF.O
93.38%
-3.69%
VEEV.N
93.33%
+3.93%
ENR.N
93.32%
-3.33%
DMAC Seasonality Analysis
Based on DMAC's historical stock price data across all years, the probability of a positive return in July is27.27%, suggesting it maynotbe an ideal month to invest in DMAC. In contrast,Februaryoffers the highest probability of positive returns at90.91%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying DiaMedica Therapeutics Inc (DMAC.O) stock in February has the highest probability of a positive return (90.91%), while July has the lowest probability (27.27%).
Performance Seasonality
The chart shows DiaMedica Therapeutics Inc. (DMAC)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy DiaMedica Therapeutics Inc (DMAC.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DMAC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying DiaMedica Therapeutics Inc (DMAC.O) stock in a year?
The radar chart shows that buying DiaMedica Therapeutics Inc (DMAC.O) stock in February has the highest probability of a positive return (90.91%), while July has the lowest probability (27.27%).
How has DiaMedica Therapeutics Inc. (DMAC)'s stock price performed over the past three years?
DMAC's stock price rose by 91.89% in 2023,increased by 91.87% in 2024, and went down by 8.35%in 2025.
Which bull technical signals does DMAC have?
Bullish technical signals of DMAC include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0, 5-day SMA crosses above 250-day SMA, 20-day SMA crosses above 60-day SMA.
Is DMAC a buy based on overall technical signals summary?
DMAC has 5 buy signals and 3 sell signals now. Overall the technical rating for DMAC is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of DMAC.
What is the trend of DiaMedica Therapeutics Inc (DMAC)'s moving average?
DiaMedica Therapeutics Inc's overall moving average trend leans more bullish as of July 25 2025, with 1 negative signals and 3 positive signal.
What is price prediction for DMAC stock next month?
The price prediction chart for DiaMedica Therapeutics Inc (DMAC.O) stock, as of July 13 2025, forecasts a -17.76% change over the next month, based on its high correlation with EU stock patterns. The similarity between their price movements over the analyzed periods is 94.23%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for DMAC Stock?
DMAC stock is predicted to reach **$4.30** in 2025, driven by its current technical setup showing a bullish MACD crossover and proximity to Fibonacci resistance levels. The stock is trading near its Fibonacci pivot point of **$3.96**, with resistance at **$4.28** and support at **$3.96**.
What is price prediction 2030 for DMAC Stock?
DMAC stock is predicted to reach **$10 by 2030**, driven by its strong progress in preeclampsia and stroke treatments, with a **138% upside** from current levels. Analysts rate it a **Strong Buy** with a **$10 price target**.